Overview

The Efficacy and Safety of Adding Methotrexate to Etanercept in Psoriasis

Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of adding methotrexate to etanercept compared with etanercept monotherapy as measured by the percentage of participants achieving a 75% improvement from baseline in the Psoriasis Area and Severity Index (PASI 75) at Week 24.
Phase:
Phase 3
Details
Lead Sponsor:
Amgen
Collaborator:
Immunex Corporation
Treatments:
Etanercept
Methotrexate